ABT Molecular Imaging
Knoxville · Founded 2006
About ABT Molecular Imaging
ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use. It was founded by Ron and Lynda Nutt in 2006 and where clinical PET was developed beginning in the early 1980s. The company was founded in 2006 by industry experts in the molecular imaging industry. ABT’s investor partners include Intersouth Partners, River Cities Capital, and two TNInvestco Funds, Council & Enhanced Tennessee Fund and Limestone Fund. The company is headquartered in Knoxville, Tennessee.
Company Facts
- Founded: 2006
- Legal name: ABT Molecular Imaging, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $28.4M
- Last round: Debt Financing (Apr 2014)
- Website: abt-mi.com
- Phone: (865) 982-0098
Social Profiles
Canonical: https://fsome.com/organization/abt-molecular-imaging-8255636 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.